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review of literature
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Abstract: Primary extranodal marginal zone lymphoma of the endometrium (PEMZL-EM) is exceedingly rare and
has not been well characterized. Herein, we study the clinicopathological, cytogenetic and molecular features of
four cases, the largest case series reported to date. The median age of the four patients was 59 years. Clinical
presentations included abnormal vaginal bleeding (three cases) and incidental finding (one case). There were no
constitutional symptoms in any of the cases. None of the patients had evidence of lymphoma in any other anatomic
sites including bone marrow. Histologically, the lymphoma was characterized by a nodular proliferation of small
lymphocytes admixed with occasional immunoblasts and variable number of plasma cells, which was restricted
to the endometrium in most cases. Lymphoepithelial lesions were not identified in any of the cases. All cases displayed the immunophenotype of marginal zone B-cell lymphoma. Cytogenetics and FISH studies revealed absence
of characteristic chromosomal translocations. Molecular analysis demonstrated immunoglobulin heavy chain gene
rearrangement in all cases, two of which were found to use IgVH3-30 gene by DNA sequencing. Three of the four
patients were still alive after a median follow-up of three years. PEMZL-EM predominantly affects postmenopausal
women and is characterized by distinct histological patterns, lack of specific genomic alterations, and indolent clinical course.
Keywords: Uterine lymphoma, marginal zone lymphoma, primary extranodal marginal zone lymphoma of the
endometrium

Introduction
Approximately 25% of non-Hodgkin lymphomas
(NHL) arise in extra-nodal sites [1, 2]. Extranodal marginal zone B-cell lymphoma (EMZL)
constitutes approximately 7-8% of NHL and is
often associated with chronic infections and
underlying autoimmune diseases [3]. Studies
have suggested that chronic antigenic stimulation may play an important role in its pathogenesis [3].
Primary lymphomas of the female genital tract
are rare, accounting for approximately 2% of all
extra-nodal lymphomas and less than 0.5% of
the gynecologic malignancies [3, 4]. Uterine
cervix is the most common site and uterine corpus involvement is very rare. The most common subtype is diffuse large B-cell lymphoma
followed by follicular lymphoma [4]. Primary

extranodal marginal zone lymphoma of the
endometrium (PEMZL-EM) is exceedingly rare
and to the best of our knowledge, only nine
cases have been described as single case
report in English literature [5-13]. Due to its low
incidence, PEMZL-EM has not been well characterized and its etiology and pathogenesis are
still unknown. In this study, we present four
cases of PEMZL-EM, which is the largest case
series ever reported, and characterize their clinicopathological, genetic and molecular features. We have also included a literature review
of all the reported cases.
Material and methods
Case selection
This study was approved by the Institutional
Review Board of North Shore-Long Island
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Table 1. Clinical and laboratory findings of four cases of PEMZL-EM
Cases

No1

No2

No3

58

59

46

72

Colonic Ca

Hepatitis C

No

No

Incidental finding

Vaginal bleeding; leiomyoma

Vaginal bleeding

Foul smelling bloody discharge

Hysterectomy

Hysterectomy; EMC

Hysterectomy; EMC

EMC, ECC

White blood cell

N/A

8.7

6

9.8

Hemoglobin

N/A

13.2

12.2

13

N/A

209

201

307

Age
Clinical history
Presentation
Specimen

Platelet
Lymphadenopathy
Site of involvement

No4

No

No

No

No

EM

EM LFT (focal)

EM

EM, sMM

Histology
Lymphoid infiltrate

Nodular

Extensive nodular

Nodular

Extensive nodular

LEL

-

-

-

-

Residual GC

-

-

+

-

BM Involvement

N/A

No

N/A

No

N/A

Kappa

Kappa

Lambda*

CD20

+

+

+

+

CD5

-

-

-

-

CD10

-

-

-

-

CD79A

+

+

+

+

CD43

+

-

-

+

cyclinD1

-

-

-

-

< 5%

< 5%

< 5%

< 5%
Clonal IgVH3-30

Immunophenotype
Surface Igs

Ki-67
IGHV

Clonal N/A

Clonal IgVH3-30

Clonal N/A

Treatment

No

No

No

No

Follow-up

2 yrs

2 yrs

4 yrs

5 yrs

Died of colonic carcinoma

Alive

Alive

Alive

Status

Abbreviations: Ca, carcinoma; EMC, endometrial curettage; ECC, endocervical curettage; EM, endometrium; sMM, superficial myometrium; LEL, lymphoepithelial lesion;
LFT, left fallopian tube; GC, germinal center; N/A, not available; BM, bone marrow. *Bone marrow.

Jewish Health system. Four cases of PEMZL-EM
were identified from the files of the Department
of Pathology at North Shore-LIJ Health System
between 1998 and 2013. Cases were considered as primary lymphomas of the endometrium only if they met the following criteria [14]:
(1) At the time of initial diagnosis, the lymphoma was primarily confined to uterine cavity and
extensive work up did not reveal evidence of
lymphoma in any other sites; (2) There was no
evidence of leukemic phase; (3) There was a
fairly long interval between the appearance of
primary lymphoma and secondary involvement.
Histology and immunohistochemistry
Paraffin-embedded tissue was available from
the diagnostic samples. Immunohistochemistry
studies were performed with a panel of prediluted antibodies including CD3, CD5, CD10,
CD20, CD23, CD43, CD79a, ki-67 (Ventana,
AZ, USA); BCL-6, Cyclin D1 (Dako, CA, USA);
BCL-2 (Zymed, CA, USA). Staining was per3037

formed using automated immunostainer (Ventana Medical System, Tucson, AZ, USA).
Flow cytometry
Single cell suspension was prepared from the
fresh tissue. Cells were stained with a panel of
fluorescence labeled monoclonal antibodies
including CD3, CD4, CD5, CD7, CD8, CD10,
CD19, CD20, CD23, FMC 7 (Becton-Dickenson
Biosciences, San Jose, California). The cells
were washed with PBS for three times and fixed
in 4% paraformadehyde PBS solution before
analysis. Routine three-color flow cytometric
analysis was performed using FACSDiva software (Becton-Dickenson Biosciences, San Jose, California).
Cytogenetics and FISH studies
Conventional karyotying was performed following the standard protocols. Interphase fluorescence in situ hybridization (FISH) analysis was
performed on either tissue imprints or paraffinembedded tissue sections using LSI dual-color,
Int J Clin Exp Pathol 2015;8(3):3036-3044
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Figure 1. Histological features of the PEMZL-EM. A. Case 3 (× 40); B. Case 1 (× 20); C. Case 2 (×40); D. Small
lymphocytes with scant cytoplasm and irregular nuclei (× 400). E. Small lymphocytes with monocytoid appearance
(400); F. Lymphoepithelial lesions are absent (× 400).

dual-fusion translocation probes (API2/MALT1
t(11;18) (q21;q21), IGH/MALT1 t(14;18) (q32;
q21), and IGH/BCL2 (Abbott Molecular, Des
Plains, IL) following the standard protocol.
Molecular studies
Genomic DNAs were prepared from paraffinembedded tissue sections using QIAamp DNA
3038

FFPE Tissue Kit (QIAGEN Inc., Valencia CA) The
quality of DNA samples was assessed using
the BIOMED-2 specimen control reaction and
all samples yielded control gene PCR products
≥ 300 bp. PCR amplifications were performed
in duplicate with commercial BIOMED-2 assays
(InVivoScribe Technologies, San Diego, CA,
USA). The reactions included three targeting
Int J Clin Exp Pathol 2015;8(3):3036-3044
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Figure 2. Representative immunohistochemistry in PEMZ-EM. A. CD3; B. CD5; C. CD20; D. cyclinD1; E. CD23; F.
ki-67.

IGH (IGHA: FR1 (variable region framework 1)-J;
IGHB: FR2-J; IGHC: FR3-J), two targeting IGK
(IGKA: V-J; IGKB: V-Kde and JC intron-Kde ) and one
for IGL(V-J) [20]. The PCR products from IGH
reactions were excised from agarose gel, purified using QIAquick Gel Extraction Kit (QIAGEN
Inc., Valencia CA), and submitted for sanger
sequencing using the common JH primer. DNA
sequence analysis was carried out using

3039

IgBLAST program of National Center for Biotechnology Information.
Results
Clinical features
Table 1 summarizes the clinical and laboratory
findings of our cases. This study included four
patients, with a median age of 59 years at the

Int J Clin Exp Pathol 2015;8(3):3036-3044
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time of initial diagnosis (range 46 to 72 years).
Three patients presented with abnormal vaginal bleeding and the lymphoma was an incidental finding in one patient. None of the patients
had constitutional symptoms at the time of initial presentation. Other significant clinical findings included colonic adenocarcinoma (case
one) and hepatitis C infection (case two). There
was no known history of Chlamydia psittaci
infection in all cases. Extensive work-up did not
reveal any evidence of lymphoma in other anatomic sites. Complete blood count was normal
in three cases with available information and
none of the patients had lymphocytosis. The
information for bone marrow staging was available in two cases, which showed no evidence of
lymphoma by morphologic examination or immunohistochemistry. All cases had Ann Arbor
stage IE disease and none of the patients
received treatment for lymphoma. After a median follow-up of three years, three patients were
still alive without disease progression and one
died of unrelated malignancy two years after
the diagnosis.
Histology and immunohistochemistry
Endometrial curettage and/or hysterectomy specimens were received for evaluation, which
showed similar histological features in all
cases. Microscopically, the endometrium was
infiltrated by lymphoid nodules composed of a
monotonous population of small to mediumsized lymphocytes (Figure 1A-C). In some cases the lymphocytes had scant cytoplasm and
slightly irregular nuclei with inconspicuous
nucleoli (Figure 1D), while in others they had
clear cytoplasm, imparting a monocytoid appearance (Figure 1E). Immunoblasts were seen
scattered throughout the infiltrate. Plasma
cells were scarce in all but one case in which
singly or small clusters of plasma cells were
found at the periphery of the lymphoid nodules.
Lymphoepithelial lesions were not seen in any
of the cases (Figure 1F). Rare small residual
germinal centers were noted within the lymphoid nodules in one case. The lymphoma was
restricted to the endometrium in three cases
and invaded the superficial myometrium in one
case. However, no evidence of cervical involvement was found in any of the cases. There was
focal mild monotonous lymphoid infiltration in
one fallopian tube in case 2, raising suspicion
(albeit not diagnostic) for minimal involvement
by lymphoma. The endometrium was atrophic
in three cases and proliferative in one case.
3040

Immunohistochemistry (Figure 2A-F) demonstrated that the neoplastic cells were positive
for CD20, CD79a and BCL-2; negative for CD5,
CD10, CD23, BCL-6 and cyclinD1. Two cases
were also CD43 positive. CD23 highlighted the
remnants of follicular dendritic meshworks
within the lymphoid nodules in one case. A
small number of reactive CD3 positive T-cells
were present in the background. All cases
showed low proliferation index (less than 5%)
as demonstrated by ki-67 staining.
Flow cytometry
Three cases had flow cytometry information
available for analysis, two from tissue specimens and one from a bone marrow specimen.
In the two tissue cases the neoplastic cells
were positive for CD19, CD20 and FMC-7; negative for CD5, CD10, and CD23. Both cases were
kappa-restricted.
Although a small clonal B-cell population was
detected by flow cytometric analysis of bone
marrow aspirate in case 4, no evidence of lymphoma was detected in bone marrow biopsy by
morphologic examination or immunohistochemistry, most consistent with monoclonal Bcell proliferation of undetermined significance.
Cytogenetics and molecular studies
We had cytogenetics or FISH data available for
analysis in three of the four cases, which
revealed no translocations that were characteristic for EMZL. In addition, there was no evidence of chromosomal rearrangement involving IGH locus in those cases. Polymerase chain
reaction (PCR) analysis of IgVH gene rearrangement was carried out using paraffin-embedded
tissue sections. In all cases a distinct band was
identified, indicating the presence of clonal
B-cells. We had sufficient material for Sanger
sequencing of the PCR products in two cases
(cases 2 and 4). Subsequent DNA sequence
analysis using NCBI IgBLAST program revealed
IgVH3-30 usage by B-cells in both cases.
Discussion
Most of the lymphomas occurring in uterus are
due to secondary involvement by systemic lymphoma, with cervix being the most common
site [4]. Primary lymphomas of the endometrium are rare; PEMZL-EM is extremely rare, with
only nine cases having been previously
Int J Clin Exp Pathol 2015;8(3):3036-3044
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Table 2. A summary of the clinical and laboratory findings of the PEMZL-EM
Case Age
no.
(years)

Clinical

Site

Histology

IHC

Clonality
F/U
Stage
Ref
by PCR
(Months)

1

81

Incidental finding; breast Ca

EM Polyp and stalk

Diffuse infiltration by small lymphocytes with
narrow rim cytoplasm; GCs (+); LEL (+); BM (-)

CD20+CD79a+IRTA1+
CD10-cyclinD1 ND

N/A

IE

24

[7]

2

61

Incidental finding;
Vaginal prolapse; hysterectomy

EM

Extensive nodular infiltrate; GCs (-); BM (N/A)

CD20+CD79a+CD5- CD10CD23-BCL-6-, cyclinD1-

+

IE

8

[8]

3

52

Postmenopausal Bleeding; Enlarged uteus Fibroid; TAH-BSO

EM, BM

Prominent infiltrate; occasional LEL;
BM (+) paratrabecular; leiomyoma

CD20+, CD5-, cyclinD1-

+

IVE

20

[9]

4

43

Intermenstrual bleeding
Hypothyroidism; TAH-BSO

EM; Iliac lymph node

N/A BM (-)

N/A

N/A

IIE

28

[10]

5

65

Postmenopausal bleeding
TAH-BSO

EM, sMM

Nodular, solid nest and sheets;
occasional GCs, LEL (-); BM (-); EM polyp

CD20+CD5-CD10BCL-6-cyclinD1-

+

IE

N/A

[11]

6

72

Pelvic pressure with dysuria
Large uterine mass
Granulomatous process
in lungs; TAH-BSO

EM, MM pelvic lymph
node

Monocytoid small lymphocytes admixed with large
cells and plasma cells; LEL (+); GCs (+); BM (-)

N/ACD20+, CD5+,
CD10-, CD23- (lymph node)

+

IIE

11a

[12]

7

80

Incidental finding; Uterovaginal
prolapse; CIN3 and early invasive
well-differentiated Ca; IgA kappa
araprotein; Vaginal hysterectomy

EM, sMM Groin
lymph node

Multiple nodules, superficial bands, perivascular and
single cell infiltrate; plasma cells (clonal); GCs (-);
LEL (-); BM (N/A)

CD20+CD5-CD10-BCL-6-IgD-

N/A

IIE

7

[6]

8

77

Incidental finding
Hysterectomy for prolapse

EM, sMM

Nodular lymphoid infiltrate with a proportion of
monocytoid cells; LEL (+); GCs (-); BM (N/A)

CD20+CD79a+CD43+
CD5-CD10-CD23- cyclinD1-

+

IAE

N/A

[5]

9

55

Vaginal bleeding
EM polyp; TAH-BSO

EM and inner ½ of MM

Nodular lymphoid infiltrate; LEL (-); GCs (1); BM (-)

CD20+CD79+CD5+
CD10-CD23-cyclinD1-

IE

30

[13]

10

59

Vaginal bleeding
Heptitis C

EM

Nodular and focal diffuse lymphoid infiltrate;
GCs (-); LEL (-), BM (-)

CD20+CD5-CD10- cyclinD1-

+

IE

24

Pre

11

72

Vaginal bleeding

EM, sMM

Nodular lymphoid infiltrate; GCs (-);
LEL (-); BM (-)

CD20CD79a+CD43+CD5CD10-CD23-BCL-6-cyclinD1-

+

IE

60

Pre

12

58

Incidental findings
Colonic cancer for staging

EM

Multiple lymphoid nodules; GCs (-);
LEL (-); BM (N/A)

CD20+CD5-CD10CD43+cyclinD1-

+

IE

24b

Pre

13

46

Vaginal bleeding

EM

Nodular lymphoid infiltrate; GCs (+);
LEL (-); BM (N/A)

CD20+CD79a+CD5-CD10cyclinD1-

+

IE

48

Pre

Abbreviations: a, radiotherapy; b, died of Ca; IHC, immunohistochemistry; F/U, follow up; Ref, reference; BM, bone marrow; Ca, carcinoma; CIN3, cervical intraepithelial neoplasia (grade 3); EM, endometrium; sMM, superficial myometrium;
GCs, germinal centers; LEL, lymphoepithelial lesion; N/A, not available; TAH-BSO, Total Abdominal Hysterectomy Bilateral Salpingo Oophorectomy; Pre, present case.

3041
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described as single case report in English literature [5-13]. This is also reflected in our study
that only four cases have been identified from
the files of a large health care system during a
period of 15 years. Our cases predominantly
affected postmenopausal woman, with a median age of 59 years. Vaginal bleeding was the
most common presentation and none of the
patients had constitutional symptoms at the
time of initial presentation. In majority of our
cases the lymphoma was confined to the endometrium. Histological findings were similar in all
cases, which was characterized by nodular lymphoid proliferation of small to medium-sized
lymphocytes with either centrocyte-like or monocytoid morphology. Lymphoepithelial lesions,
the pathognomonic feature of EMZL, were not
seen in any of our cases. Plasmacytic differentiation was absent in all but one case. Residual
germinal centers were rare. The nodular lymphoid proliferation pattern is quite characteristic for PEMZL-EM, which is uncommon for EMZL
arising in other anatomic sites. All cases demonstrated the immunophenotype of marginal
zone lymphoma, of which two expressed CD43.
In all the cases, the diagnosis of lymphoma was
supported by morphology, immunohistochemistry, and molecular analysis. Three of our
patients were alive with no evidence of disease
after a median follow-up of three years and one
patient died of an unrelated malignancy.
Although the follow-up period is relatively short,
it appears that our patients had indolent clinical courses.
To further characterize this entity, we summarize the clinicopathological features of thirteen
cases of PEMZL-EM including our cases in
Table 2. The median age was 61 years (range,
43 to 81 years). The clinical presentation included the followings in descending order:
abnormal vaginal bleeding (n=7), incidental
finding (n=5), and pelvic pressure with dysuria
(n=1). Other significant findings included cancer (n=3), endometrial polyps (n=3), leiomyomata (n=2), hepatitis C (n=1), hypothyroidism
(n=1), and IgA paraprotein (n=1). In a majority
of the cases (9/13) the lymphoma was limited
to uterine corpus, only three cases had local
lymph node involvement, and one case had
bone marrow involvement. The histological findings were characteristic and the immunophenotype was that of marginal zone lymphoma in
all but two cases. One case with CD5 positivity
had regional lymph node involvement, for which
he received radiation therapy. Only a subset of
3042

the reported cases had cytogenetics or FISH
information available for analysis, which did not
show the characteristic genetic alterations. The
clinical course appeared to be indolent, with 10
out of 11 patients reported to be alive after a
median follow-up of two years [5-13].
The etiology and pathogenesis of EMZL is still
unclear and it has been speculated that antigen stimulation may play an important role.
EMZL is often associated with chronic infections and autoimmune diseases. Examples of
infectious organisms that may cause EMZL in
mucosal or cutaneous sites include Helicobacter pylori (gastric mucosal-associated lymphoid tissue or MALT lymphoma), Chlamydia
psittaci (ocular adnexal EMZLlymphoma), Campylobacter jejuni (immunoproliferative small
intestinal disease), and Borrelia burgdoferi
(cutaneous EMZL) [3]. However, there is no evidence of chronic endometritis in this cohort
although human papillomavirus or hepatitis C
virus was detected in two patients. Hepatitis C
has been associated with nodal marginal zone
lymphoma. In addition, no evidence of Chlamydia psittaci infection was observed in our
cases, which has not been reported in other
PEMZL-EM cases. Three characteristic chromosomal translocations have been described in
EMZL of other sites: t(11;18)(q21;q21), t(1;14)
(p22;q23) and t(14;18)(q21;q32) [15, 16]. The
presence of these translocations is often associated with chronic infections and activation of
NF-KB pathway [17]. Other genetic alterations
such as trisomies also have been reported in
EMZL arising in other sites [15, 16]. Although
EMZL may carry one of these abnormalities,
the incidence is variable depending on the anatomic sites and geographic locations. However,
none of the translocations have been found in
EMZL occurring at uncommon sites such as
breast and prostate and, in our case, the endometrium [14, 15]. Furthermore, these translocations are also not detected in C. psittaci negative ocular adnexal extranodal marginal zone
lymphoma (C psittaci-negative OAEMZL) [17].
These findings suggest that factors other than
chronic infections may play an important role in
the pathogenesis of these subtypes of EMZL
and further studies are needed to identify the
underlying molecular mechanisms.
In order to address this issue, we studied the
usage of IgVH genes in our cases, which have
not been previously explored. We acquired sufficient DNA for sequence analysis in two cases.
Int J Clin Exp Pathol 2015;8(3):3036-3044
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Surprisingly, in both cases the B-cells used
IgVH3-30 family, which frequently encodes
autoantibodies. Biased usage of IgVH3-30 has
been reported at a higher frequency in C psittaci-negative OAEMZL and H. pylori eradicationresponsive and API2-MALT1 fusion-negative
gastric EMZL [18, 19]. These findings suggest
that chronic interaction with a biased immunoglobulin family subset with an unknown antigen
may play a role in the pathogenesis of PEMZLEM. However, the case number is too small to
draw a definitive conclusion.
Our series of four patients with PEMZL-EM
shows that this entity predominantly affects
postmenopausal women and is characterized
by distinct histologic features, characteristic
immunophenotype, lack of specific genetic
alterations, and indolent clinical course. We are
the first to study the usage of IgVH gene in
PEMZL-EM and found biased use of the IgVH330 family in two cases. Our findings suggest
that chronic antigen stimulation may play an
important role in the pathogenesis of PEMZL-EM.
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